YORKSHIRE Cancer Research (YCR), the largest independent regional cancer charity in England, has appointed Dr Kathryn Scott as its new chief executive.

Dr Scott, who was born and grew up in Bradford, joined the charity in 2008 and previously held the position of director of research and innovation.

She succeeds Charles Rowett, who had led the organisation, a partner in the successful Telegraph & Argus Bradford Crocus Cancer Appeal, since June 2012.

Dr Scott was “integral” in formulating the charity’s ten-year strategy which aims to invest £100 million across Yorkshire by 2025 so at least 2,000 more people survive cancer every year.

Dr Scott spent a decade working in cancer research in universities across Yorkshire and said she saw how working collaboratively could speed progress and bring direct patient benefits.

YCR said figures showed that Yorkshire has the third worst cancer incidence rates in England, with survival rates for many of the most common cancers below the national average.

In 2016, the area covered by the NHS Bradford City Clinical Commissioning Group had the lowest take-up rate anywhere in England for bowel cancer screenings over a 30-month period to 2014, and the third-worst national rate for breast cancer.

YCR says its aims to lower incidence and increase survival rates in every part of the region by leading local community health initiatives and improving access to treatment and care.

Dr Scott said: “I’m extremely pleased to have been given the opportunity to continue the progress we have already made in ensuring the work we fund has the best possible impact on the people of Yorkshire.

“We know our region has specific cancer problems caused by a number of factors, including social deprivation and lifestyle choices. I passionately believe that by working with other health organisations, universities, and teaching hospitals we can change this. By focusing on cancer prevention, promoting early diagnosis, pioneering new treatments, and improving care and support, we can save lives.”